About this trial

This observational study aims to evaluate multiple dimensions of health in patients with Obstructive Sleep Apnea Syndrome (OSAS), before and after three weeks of ventilotherapy.

Specifically, the study aims to identify pre- vs post-treatment differences in the following domains:

* cognitive performance * blood expression of biomarkers related to neurodegeneration * psychosocial wellbeing

Thus, patients will complete the following evaluations before (T0) and after (T1) ventilotherapy:

* neuropsychological standard assessment * blood sampling * psychosocial self-reported questionnaires

Eligibility criteria

Qualifiers

OSAS diagnosis (AHI > 5)

handedness: right

Disqualifiers

previous ventilotherapy

neurological and/or neurodegenerative conditions

Personality disorders, autism spectrum disorders, schizophrenia, psychosis

sleep disorders comorbidities (eg., narcolepsy)

Trial design

Treatments tested in this trial

  • Continuous Positive Airway Pressure Ventilotherapy

Treatment groups

No treatment groups listed

Locations

1
IRCCS Istituto Auxologico Italiano28824, PiancavalloVCO, Italy

Sponsors and collaborators

Istituto Auxologico Italiano

Lead sponsor